“…Findings from PET studies are being translated into SPECT (Wagner, 1986), initially with iodine-123 compounds and, more recently, with technetium-99m agents such as exametazime. These have been demonstrated in a number of studies where the SPECT findings have been analogous to those found with PET, for example in epilepsy (Holman et a!, 1982;Biersak et a!, 1985;Podreka et a!, 1987), dementia (Cohen et a!, 1986;Sharp et a!, 1986), cerebral infarction (Holman et a!, 1982;Podreka et a!, 1987), and psychiatric and extrapyramidal disorders (Podreka et a!, 1987). However, as the principal agents used for many of the PET studies, fluorine-l8 deoxyglucose is an index of metabolic activity and technetium-99m exametazime is an indication of perfusion, and absolute comparisons are not strictly compatible physiologically.…”